Press Releases
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis
Genzyme, aSanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO® (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS). The TGA approval will...
Press Releases
PerkinElmer Establishes New Direct Operations in Southern Africa to Expand Its Presence & Business in the Fast Developing Region
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened direct operations in Midrand, South Africa. The new PerkinElmer Southern African headquarters...
Press Releases
Diffusion Pharmaceuticals Successfully Completes Phase I Brain Cancer Trial
Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain...
Press Releases
State of the Cure Report Finds Funding of Cure Research for Type 1 Diabetes Drops by Half
On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the only analytical and comprehensive review of progress made toward a type 1 diabetes cure...
Press Releases
BioTime and BioTime Acquisition Corporation Announce Combined $10 Million Financing
BioTime, Inc. and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent for a $10 million investment from a private investor to provide financing for the...
Press Releases
GE Healthcare scientist paired with Cardiff MP to share insights on cell therapy, science and policy-making
Dr. Michelle Janas from GE Healthcare Life Sciences recently swapped a lab coat for legislation, when she visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a unique ‘pairing’ scheme...
Press Releases
Simcyp Signs Collaborative Research Agreement with US FDA to Extend Dog Simulator to Veterinary Medicines
Simcyp (now Certara) has entered into a Cooperative Research and Development Agreement (CRADA) with the US Food and Drug Administration (FDA) to further develop the Simcyp Dog model for the evaluation of drug products intended for use in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read